BeStock  
Stocks › Biotechnology › FDMT

4D Molecular Therapeutics FDMT

US equityMarket cap rank #3514Biotechnology
$12.59 +$0.03 (+0.24%)
Pre-market · Oct 8, 8:10 am ET · After hours $12.59 0.00%
Open$12.36
Prev close$12.56
Day range$12.19 – $12.92
Volume603.6K
Market cap$695.52M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-4.8x
CheapRich

Below its usual level · 38th percentile, 5-year average -4.3x

Price / book1.7x
CheapRich

Around its usual level · 58th percentile, 5-year average 1.7x

#2629 of 5317 stocks by PB (1 = cheapest)

Price / sales7.6x
CheapRich

Near the bottom of its 5-year range · 8th percentile, 5-year average 2,484.8x

#4239 of 5146 stocks by PS (1 = cheapest)

P/E over five years

-14x-9x-5x0xOct '21Apr '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$18.02
Price vs. fair value-30.1%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.71 – 1.75 58% (pricier than usual) #2629 of 5317 (1 = cheapest)
PE -4.79 -2.29 -4.32 38% (cheaper than usual) –
PS 7.56 46.46 2,484.85 8% (cheaper than usual) #4239 of 5146 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★★
Fair value estimate$18.02
Economic moatNone
UncertaintyVery High

Discussion

No comments yet — be the first to weigh in on FDMT.

Leave a comment

Scroll to Top